News

The decision to scale back recommendations has raised concerns about insurance coverage and future access to COVID vaccines.
Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...
Previously, the FDA recommended COVID-19 vaccines for everyone aged 6 months and older. Under the new plan, shots for healthy kids and adults will need to go through placebo-controlled clinical trials ...
The move could alter guidance for doctors as well as some insurance coverage. Health and Human Services Secretary Robert F. Kennedy Jr. on Tuesday announced the removal of the COVID-19 vaccine ...
The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled trials before they’re licensed for use, raising urgent questions about the ...
The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical ...
He is also demanding an inquiry into whether records were ... and other information relating to the COVID-19 pandemic and the vaccines must be thoroughly investigated.” Johnson and other ...
The inquiry focused on vaccines and mandates; the lockdowns; and tools such as testing and tracing. The coalition government had also widened the scope of the inquiry to seek feedback on issues such ...
The Food and Drug Administration (FDA) announced plans to significantly curtail people’s access to Covid-19 vaccines.